Decreased PPAR-γ Expression in the Conjunctiva and Increased Expression of TNF-α and IL-1β in the Conjunctiva and Tear Fluid of Dry Eye Mice.

Yihui Chen,Xiaoyan Zhang,Ling Yang,Min Li,Bing Li,Weifang Wang,Minjie Sheng
DOI: https://doi.org/10.3892/mmr.2014.2041
IF: 3.423
2014-01-01
Molecular Medicine Reports
Abstract:The aim of this study was to investigate the expression of peroxisome proliferator-activated receptor gamma (PPAR-gamma), tumor necrosis factor (TNF)-alpha and interleukin (IL)-1 beta in the conjunctiva and the association between inflammatory cytokines and PPAR-gamma in dry eye mice. Dry eye was induced in 6-week-old female C57 mice. mRNA expression of PPAR-gamma, TNF-alpha and IL-1 beta were measured. PPAR-gamma protein expression in the conjunctiva, and the contents of TNF-alpha and IL-1 beta in the conjunctiva and tear-wash fluid were determined. A PPAR-gamma agonist, pioglitazone (PIO), was used to treat dry eye mice. Dry eye mice presented with similar manifestations as in humans. The PPAR-gamma expression in the conjunctiva of dry eye mice was downregulated, accompanied by increased contents of TNF-alpha and IL-1 beta. PIO treatment markedly reduced the contents of TNF-alpha and IL-1 beta in tear fluid of dry eye mice. Following PIO treatment, the PPAR-gamma expression increased markedly. PIO may activate PPAR-gamma to inhibit the expression of the inflammatory cytokines TNF-alpha and IL-1 beta in dry eye mice. This suppresses the inflammatory progression, increases the tear fluid production, elevates the tear film stability and reduces the damage to the ocular surface, exerting a therapeutic effect on dry eye.
What problem does this paper attempt to address?